Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer

Indoleamine 2,3-dioxygenase (IDO) has recently been proposed to account for tumor-induced immunosuppression by influencing the conversion of tryptophan (Trp) into kynurenine (Kyn). The objective of our study was to correlate IDO activity with disease outcome in non-small cell lung cancer (NSCLC) pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Creelan, Ben C., Antonia, Scott, Bepler, Gerold, Garrett, Timothy J., Simon, George R., Soliman, Hatem H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661168/
https://www.ncbi.nlm.nih.gov/pubmed/23802083
http://dx.doi.org/10.4161/onci.23428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661168/
https://www.ncbi.nlm.nih.gov/pubmed/23802083
http://dx.doi.org/10.4161/onci.23428

Ejemplares similares